These mice, which will be referred to as the severe FSHD-like model, similarly showed DUX4-FL expression by 3 days after the first injection (severe day 3, or SD3) and peak DUX4-FL expression at SD6. This evidence concerns the gene FLT3LG and facioscapulohumeral muscular dystrophy.